2022
DOI: 10.1016/j.sajb.2021.09.022
|View full text |Cite
|
Sign up to set email alerts
|

Coumarins from Seseli petraeum M. Bieb. (Apiaceae) and their α-glucosidase inhibitory activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 24 publications
0
3
0
Order By: Relevance
“…Several coumarins were tested for their inhibitory activity against α-amylase and α-glycosidase, and were found to show prominent inhibitory activity against α-glycosidase and a low inhibitory potential against α-amylase. Octanoyllomatin was the best inhibitor of a-glycosidase (IC50 = 69.00 ± 0.43 µg/mL) [61].…”
Section: Other Activitiesmentioning
confidence: 94%
“…Several coumarins were tested for their inhibitory activity against α-amylase and α-glycosidase, and were found to show prominent inhibitory activity against α-glycosidase and a low inhibitory potential against α-amylase. Octanoyllomatin was the best inhibitor of a-glycosidase (IC50 = 69.00 ± 0.43 µg/mL) [61].…”
Section: Other Activitiesmentioning
confidence: 94%
“…The results unveiled notable and significant inhibitory effects [28] . Similarly, a coumarin called octanoyllomatin isolated from the hexane extract of Seseli petraeum exhibited significant inhibition of the α ‐glucosidase enzyme [29] . Additionally, a hexane extract from Ferula haussknechtii flowers showed significant inhibitory effects on α ‐glucosidase activity [30]…”
Section: Resultsmentioning
confidence: 99%
“…In this context, there is a necessity to explore and develop new natural antidiabetic candidates. Previous records indicated the therapeutic effects of coumarins and their derivatives on diabetes; fraxetin significantly decreased BGL as well as glycosylated hemoglobin and increased the plasma insulin level at a dose of 80 mg/kg body weight [ 36 ] and octanoyllomatin exhibited a prominent α-glucosidase inhibition with IC50 value (69 µg/mL) [ 37 ]. Further examples include peucedanol glucoside, which showed a 39% reduction in postprandial hyperglycemia at a dose of 5.8 mg/kg [ 38 ], and umbelliferone, which revealed a notable antihyperglycemic effect comparable to GB at a dose of 30 mg/kg body weight [ 39 ].…”
Section: Discussionmentioning
confidence: 99%